|
Elevai Labs, Inc. Common Stock (ELAB) DCF Valuation |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
Elevai Labs, Inc. Common Stock (ELAB) Bundle
Evaluate Elevai Labs, Inc. Common Stock's (ELAB) financial outlook like an expert! This (ELAB) DCF Calculator provides you with pre-filled financial information and the complete flexibility to modify revenue growth, WACC, profit margins, and other critical assumptions to align with your projections.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .8 | 1.7 | 2.5 | 4.0 | 6.4 | 10.3 | 16.6 | 26.7 |
| Revenue Growth, % | 0 | 0 | 92557.44 | 123.5 | 44.07 | 61.02 | 61.02 | 61.02 | 61.02 | 61.02 |
| EBITDA | .0 | -.8 | -1.8 | -4.3 | -3.2 | -2.4 | -3.8 | -6.2 | -10.0 | -16.0 |
| EBITDA, % | 100 | -94594.92 | -232.52 | -249.35 | -129.63 | -60 | -60 | -60 | -60 | -60 |
| Depreciation | .2 | .0 | .0 | .0 | .1 | 1.6 | 2.6 | 4.2 | 6.8 | 10.9 |
| Depreciation, % | 100 | 333.37 | 0.84982 | 0.6802 | 3.37 | 40.98 | 40.98 | 40.98 | 40.98 | 40.98 |
| EBIT | -.2 | -.8 | -1.8 | -4.3 | -3.3 | -2.4 | -3.8 | -6.2 | -10.0 | -16.0 |
| EBIT, % | 100 | -94928.3 | -233.37 | -250.03 | -133 | -60 | -60 | -60 | -60 | -60 |
| Total Cash | .0 | .4 | 1.2 | 3.3 | 4.0 | 4.0 | 6.4 | 10.3 | 16.6 | 26.7 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .0 | .0 | 1.6 | 2.6 | 4.2 | 6.8 | 10.9 |
| Account Receivables, % | 100 | 206.77 | 1.68 | 2.11 | 0.21384 | 40.8 | 40.8 | 40.8 | 40.8 | 40.8 |
| Inventories | .0 | .2 | .2 | .5 | .0 | 2.1 | 3.3 | 5.3 | 8.6 | 13.8 |
| Inventories, % | 100 | 19445.83 | 30.03 | 28.94 | 0.04231349 | 51.8 | 51.8 | 51.8 | 51.8 | 51.8 |
| Accounts Payable | .0 | .1 | .2 | .6 | .5 | 2.2 | 3.6 | 5.8 | 9.3 | 15.1 |
| Accounts Payable, % | 100 | 11871.22 | 27.51 | 34.81 | 19.5 | 56.36 | 56.36 | 56.36 | 56.36 | 56.36 |
| Capital Expenditure | .0 | .0 | .0 | .0 | .0 | -.8 | -1.4 | -2.2 | -3.5 | -5.6 |
| Capital Expenditure, % | 100 | -3927.57 | -4.64 | -0.65345 | -0.37126 | -21.13 | -21.13 | -21.13 | -21.13 | -21.13 |
| Tax Rate, % | -55.49 | -55.49 | -55.49 | -55.49 | -55.49 | -55.49 | -55.49 | -55.49 | -55.49 | -55.49 |
| EBITAT | -.2 | -.8 | -1.8 | -4.3 | -5.1 | -2.4 | -3.8 | -6.2 | -10.0 | -16.0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | .0 | -.9 | -1.8 | -4.2 | -4.6 | -3.5 | -3.4 | -5.6 | -8.9 | -14.4 |
| WACC, % | 5.22 | 5.22 | 5.22 | 5.22 | 5.22 | 5.22 | 5.22 | 5.22 | 5.22 | 5.22 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -29.7 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -15 | |||||||||
| Terminal Value | -456 | |||||||||
| Present Terminal Value | -353 | |||||||||
| Enterprise Value | -383 | |||||||||
| Net Debt | -4 | |||||||||
| Equity Value | -379 | |||||||||
| Diluted Shares Outstanding, MM | 0 | |||||||||
| Equity Value Per Share | -16,673.63 |
What You Will Receive
- Authentic Elevai Data: Comprehensive financial insights, including revenue and EBIT, derived from actual and projected metrics.
- Complete Customization: Modify all essential parameters (highlighted in yellow) such as WACC, growth percentage, and tax rates.
- Immediate Valuation Adjustments: Automatic recalculations that allow you to assess the effects of modifications on Elevai Labs’ fair value.
- Flexible Excel Template: Designed for quick updates, scenario analyses, and detailed forecasting.
- Efficient and Precise: Eliminate the need to create models from the ground up while ensuring accuracy and adaptability.
Key Features
- Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for Elevai Labs, Inc. (ELAB).
- WACC Calculator: Comes with a pre-configured Weighted Average Cost of Capital sheet allowing for customizable inputs.
- Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates as needed.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specific to Elevai Labs, Inc. (ELAB).
- Interactive Dashboard and Charts: Visual summaries present essential valuation metrics for straightforward analysis.
How It Works
- Step 1: Download the prebuilt Excel template featuring Elevai Labs, Inc. (ELAB) data.
- Step 2: Navigate through the pre-filled sheets to familiarize yourself with the key metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly view the updated results, including the intrinsic value of Elevai Labs, Inc. (ELAB).
- Step 5: Use the outputs to make well-informed investment decisions or create comprehensive reports.
Why Choose Elevai Labs, Inc. (ELAB) Calculator?
- User-Friendly: Tailored for both novice and seasoned users.
- Customizable Parameters: Adjust inputs easily to suit your analysis needs.
- Real-Time Updates: Monitor immediate changes to Elevai's valuation as you alter inputs.
- Preloaded Data: Comes equipped with Elevai's actual financial metrics for efficient evaluations.
- Preferred by Experts: Utilized by investors and analysts for making well-informed decisions.
Who Should Use Elevai Labs, Inc. Common Stock (ELAB)?
- Investors: Assess Elevai Labs' fair value to make informed investment choices.
- CFOs: Utilize a robust DCF model for comprehensive financial reporting and analysis.
- Consultants: Customize the template efficiently for client valuation reports.
- Entrepreneurs: Discover financial modeling techniques employed by leading corporations.
- Educators: Employ it as a practical resource for teaching valuation methods.
Contents of the Template
- Pre-Filled DCF Model: Elevai Labs, Inc.'s financial data already integrated for immediate analysis.
- WACC Calculator: Comprehensive calculations for the Weighted Average Cost of Capital.
- Financial Ratios: Assess Elevai Labs, Inc.'s profitability, leverage, and operational efficiency.
- Editable Inputs: Modify assumptions such as growth rates, profit margins, and capital expenditures to align with your scenarios.
- Financial Statements: Access annual and quarterly reports to facilitate in-depth evaluations.
- Interactive Dashboard: Effortlessly visualize essential valuation metrics and outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.